Payment & Practice Management  |   December 2016
Interlaminar Epidurals in 2017
Article Information
Practice Management / Radiological and Other Imaging / Respiratory System / Payment & Practice Management
Payment & Practice Management   |   December 2016
Interlaminar Epidurals in 2017
ASA Monitor 12 2016, Vol.80, 54-56.
ASA Monitor 12 2016, Vol.80, 54-56.
There is very little doubt that 2017 will be a pivotal year in physician payments. In its April 2016 proposed rule for implementation of the Medicare Access and CHIP Reauthorization Act (MACRA), the Centers for Medicare & Medicaid Services (CMS) proposed that performance in 2017 will impact payments issued in 2019. MACRA and its new methods for determining Medicare payment is not the only change we will see in 2017.
Interlaminar epidural injections have been the subject of attention every year since CMS placed these codes on its list of potentially misvalued services in its final rule for the CY 2012 Medicare Physician Fee Schedule (MPFS). In 2012, ASA led a multispecialty effort to address CMS’s concerns about the valuation of these services. ASA and six other societies whose members perform these services conducted surveys per the AMA/Specialty Society RVS Update Committee (RUC) process and presented the results of those surveys to the RUC in October 2012. After a vigorous review, the RUC recommended maintaining the current values (work relative value units [RVUs]) for three of the four codes reviewed. Unfortunately, CMS did not agree and dramatically lowered the values of these services. Those reduced values were used to determine Medicare payments for these services for CY 2014
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Affiliation & Institution
I have a potential conflict of interest
Comment Title

This feature is available to Subscribers Only
ASA Member Login or Create an Account ×